StockTipsArenaBeta

BUY Pfizer Limited — Aastha Jain, Hem Securities

BUYPfizer Limited
Pfizer share price target & all analyst calls

byAastha Jain, Hem SecuritiesHorizon: BTST3 Aug 2026, 3:05 pm ISTvia Zee Business (Live)

Entry₹4,919.6Inferred
Target₹5,050
Total upside +2.65% (call closed)
Stop loss₹4,800-2.43% risk
At expiry₹4,853.64 Aug 2026, 3:20 pm
Expired-1.34%
Follow Aastha Jain for new calls(22% target hit, 69 closed calls)Get alertsWatch PFIZER for new buy/sell callsGet alertsSee 3 active BTST picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 4 Aug 2026
2 supporting2 neutral0 opposing
Supports the BUY call (2)

Pfizer Q1 Results: Net Profit Jumps 7%, Revenue Marginally Increases To Rs 653 Crore

NewsNdtv-Profit·28 Jul · 1w ago

(opens in new tab)

Pfizer Q1 Results: Net profit, revenue rise from last year; margin expands

NewsCnbc-Tv18·28 Jul · 1w ago

(opens in new tab)
Neutral / worth noting (2)

Pfizer Limited announced its unaudited financial results for the quarter ended June 30, 2026, approved by the Board of Directors. The company also submitted its limited review report.

NSE · Outcome of Board Meeting·28 Jul · 1w ago

(opens in new tab)

Pfizer Ltd announced its unaudited financial results for the quarter ended June 30, 2026, approved by the Board of Directors. The limited review report from statutory auditors is also enclosed.

BSE · Board Meeting·28 Jul · 1w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Pfizer

All analyst calls on Pfizer

More from Aastha Jain, Hem Securities

Every call and its outcome